0000000001255325

AUTHOR

Fabrizio Tremolaterra

showing 1 related works from this author

A randomised clinical trial (RCT) of a symbiotic mixture in patients with irritable bowel syndrome (IBS): effects on symptoms, colonic transit and qu…

2012

Purpose The aim of this study is to test in a double-blinded, randomised placebo-controlled study the effects of a commercially available multi-strain symbiotic mixture on symptoms, colonic transit and quality of life in irritable bowel syndrome (IBS) patients who meet Rome III criteria. Background There is only one other double-blinded RCT on a single-strain symbiotic mixture in IBS. Methods This is a double-blinded, randomised placebo-controlled study of a symbiotic mixture (Probinul, 5 g bid) over 4 weeks after 2 weeks of run-in. The primary endpoints were global satisfactory relief of abdominal flatulence and bloating. Responders were patients who reported at least 50 % of the weeks of …

AdultMalemedicine.medical_specialtyAbdominal painPrebioticSymbioticProbioticGastroenterologyRandomised clinical trialMedication Adherencelaw.inventionIrritable Bowel SyndromeBloatingQuality of lifeRandomized controlled triallawInternal medicinemedicineFlatulenceHumansGastrointestinal TransitSymbiosisIrritable bowel syndromeDemographyPain Measurementbusiness.industryBloatingProbioticsdigestive oral and skin physiologyGastroenterologyHepatologymedicine.diseasedigestive system diseasesAbdominal PainDietClinical trialQuality of LifeOriginal ArticleFemalemedicine.symptombusinessFlatulenceInternational Journal of Colorectal Disease
researchProduct